¼¼°èÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå - »ê¾÷ ±Ô¸ð, µ¿Çâ, ±âȸ, ¿¹Ãø, À¯Çüº° ºÎ¹®, ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹®, Áö¿ªº° ºÎ¹®, °æÀï,2020-2030¿¬´ë
Pancreatic Cancer Therapeutics & Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type, By End-User By Region & Competition, 2020-2030F
»óǰÄÚµå : 1698065
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 46¾ï ´Þ·¯¿¡ ´ÞÇß°í, 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 7.50%ÀÇ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ¼¼°è ½ÃÀåÀº °¡Àå Ä¡¸íÀûÀÎ ¾Ï Áß ÇϳªÀÎ ÃéÀå¾Ï¿¡ ´ëÇÑ ±ä±ÞÇÑ ´ëÀÀÀÌ ÇÊ¿äÇÔ¿¡ µû¶ó ÇコÄÉ¾î »ê¾÷¿¡¼­ ¿ªµ¿ÀûÀ¸·Î ÁøÈ­Çϰí ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 46¾ï ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 71¾ï 2,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 7.50%
±Þ¼ºÀå ºÎ¹® Ä¡·á
ÃÖ´ë ½ÃÀå ºÏ¹Ì

ÃéÀå¾ÏÀº ºñ±³Àû µå¹® ¾ÏÀ¸·Î Àüü ¾Ï ȯÀÚ¿¡¼­ Â÷ÁöÇÏ´Â ºñÀ²Àº Àû½À´Ï´Ù. ±×·¯³ª °¡Àå Ä¡»çÀ²ÀÌ ³ôÀº ¾Ï Áß ÇϳªÀÌ¸ç »ýÁ¸À²ÀÌ ³·½À´Ï´Ù. ÃéÀå¾ÏÀÇ ¹ßº´·üÀº Áö¿ª¿¡ µû¶ó ´Ù¸£¸ç, Áö¿ª¿¡ µû¶ó ¹ßº´·üÀÌ ³ôÀº °÷µµ ÀÖ½À´Ï´Ù. À§ÇèÀÎÀڷδ ³ªÀÌ, °¡Á··Â, Èí¿¬, ºñ¸¸, ƯÁ¤ À¯ÀüÀÚ º¯ÀÌ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÃéÀå¾Ï ¹ß»ý·ü Áõ°¡

ÁÖ¿ä ½ÃÀå À̽´

³ôÀº Ä¡·áºñ

ÁÖ¿ä ½ÃÀå µ¿Çâ

°³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ÃéÀå¾Ï Ä¡·áÁ¦ ¹× Áø´Ü¾à ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå Àü·«Àû Á¦¾È

Á¦16Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pancreatic Cancer Therapeutics & Diagnostics Market was valued at USD 4.60 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 7.50% through 2030. The Global Pancreatic Cancer Therapeutics & Diagnostics Market is a dynamic and evolving sector of the healthcare industry, driven by the urgent need to combat one of the deadliest forms of cancer.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.60 Billion
Market Size 2030USD 7.12 Billion
CAGR 2025-20307.50%
Fastest Growing SegmentTreatment
Largest MarketNorth America

Pancreatic cancer is a relatively rare cancer, accounting for a small percentage of all cancer cases. However, it is one of the most lethal forms of cancer, with a low survival rate. The incidence of pancreatic cancer varies by region, with some areas experiencing higher rates than others. Risk factors include age, family history, smoking, obesity, and certain genetic mutations.

Key Market Drivers

Rising Incidence of Pancreatic Cancer

The increasing incidence of pancreatic cancer is a major driving force behind the expansion of the Global Pancreatic Cancer Therapeutics & Diagnostics Market. Pancreatic cancer remains one of the most lethal malignancies, posing a significant challenge to global healthcare systems. In 2020, approximately 500,000 new cases were reported worldwide, with 470,000 fatalities, underscoring the disease's high mortality rate. The global incidence rate stood at 4.9 cases per 100,000 people, while the mortality rate reached 4.5 per 100,000, highlighting the urgent need for more effective diagnostic and therapeutic interventions. This trend is influencing the demand for advanced treatment options, early diagnostic solutions, and improved healthcare infrastructure. Pancreatic cancer is among the most aggressive malignancies, with a high mortality rate. Due to late-stage diagnoses and limited treatment options, the survival rate remains low. The five-year survival rate for pancreatic cancer varies significantly based on the stage at diagnosis. For patients diagnosed at an early, operable stage, the survival rate reaches 20%. However, when considering all cases-including advanced, inoperable stages-the overall five-year survival rate drops to just 5%. The rising number of diagnosed cases worldwide is directly fueling the demand for innovative therapeutic solutions, including chemotherapy, immunotherapy, targeted therapy, and personalized medicine.

Key Market Challenges

High Treatment Costs

Pancreatic cancer treatment can be prohibitively expensive. The disease often necessitates aggressive interventions, including surgery, chemotherapy, radiation therapy, and personalized targeted therapies. These treatments not only involve substantial direct medical costs but also indirect costs related to hospitalization, supportive care, and managing side effects. Additionally, the complexity of pancreatic cancer cases often requires specialized healthcare providers and facilities, further driving up costs.

High treatment costs pose financial burdens on patients, healthcare systems, and insurers. This can limit patient access to advanced therapies and diagnostics, impacting market growth. Moreover, it can lead to delays in seeking treatment and influence treatment choices based on cost considerations rather than optimal clinical outcomes.

Key Market Trends

Advancements in Personalized Medicine

Personalized medicine is a significant trend in the treatment of pancreatic cancer. This approach tailors treatment plans based on an individual patient's genetic makeup, tumor characteristics, and other factors. Advancements in genomics and molecular profiling technologies have made it possible to identify specific mutations and biomarkers associated with pancreatic cancer. This trend is driven by the need for more effective and targeted therapies, as standard treatments have shown limited success in improving survival rates for pancreatic cancer patients.

The adoption of personalized medicine is expanding the range of therapeutic options available in the market. Pharmaceutical companies are developing targeted therapies that address specific genetic mutations, offering new hope for patients. Diagnostic tools that enable genetic profiling and guide treatment decisions are also in high demand. This trend is expected to drive market growth as more personalized treatment approaches become available.

Key Market Players

Report Scope:

In this report, the Global Pancreatic Cancer Therapeutics & Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pancreatic Cancer Therapeutics & Diagnostics Market, By Type:

Pancreatic Cancer Therapeutics & Diagnostics Market, By End User:

Pancreatic Cancer Therapeutics & Diagnostics Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pancreatic Cancer Therapeutics & Diagnostics Market.

Available Customizations:

Global Pancreatic Cancer Therapeutics & Diagnostics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

6. North America Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

7. Europe Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

8. Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

9. South America Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

10. Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Pancreatic Cancer Therapeutics & Diagnostics Market: SWOT Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â